Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer
Guoshun Luo(China Pharmaceutical University), Hua Xiang(China Pharmaceutical University), Xin Wang(Clemson University), Luyu Ma(China Pharmaceutical University), Shengnan Ren(Second Military Medical University), Shuangjie Wu(China Pharmaceutical University), Xin Lin(Central South University)
Cited by 20
Related Papers
Photoinduced electron transfers with carbon dots
|Chemical Communications|2009|799
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against Cancer
|ACS Nano|2013|270
Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal Imaging
|Nano Letters|2011|263